Terminal breast cancer patients push for PHARMAC inquiry and the funding of life-preserving drugs

13 March 2019 - Crowd-funding website Givealittle shouldn't be used to plug the gaps in Government drug-buying agency Pharmac's provisions ...

Read more →

PHARMAC funding should be doubled - breast cancer advocate

13 March 2019 - A breast cancer advocate believes PHARMAC needs to have its funding doubled to better serve New ...

Read more →

Women with advanced breast cancer ask health select committee for PHARMAC review

13 March 2019 - Ten women today spoke one after the other, telling a committee of MPs how desperately they ...

Read more →

Decision to make changes to funded haemophilia treatments

8 March 2019 - PHARMAC is pleased to announce changes to funded haemophilia treatments that will result in two new ...

Read more →

Quebec appeals court orders province to restore full coverage of rheumatoid-arthritis drug Remicade

13 February 2019 - Quebec’s highest court has ordered the provincial government to restore full public coverage of Remicade, an ...

Read more →

Universal medicine access through lump-sum remuneration — Australia’s approach to hepatitis C

14 February 2019 - Australia’s agreement to spend about 1 billion Australian dollars (U.S.$766 million) over 5 years in exchange for ...

Read more →

Time for inquiry into PHARMAC's funding of cancer drugs

4 February 2019 - Labour promised voters world class cancer care but, of all the rocks I've looked under, I ...

Read more →

Decision to open access to atomoxetine and change funded brand

31 January 2019 - PHARMAC is pleased to announce that all funding restrictions on atomoxetine will be removed from 1 ...

Read more →

UPMC Health Plan announces innovative, value-based agreement with AstraZeneca

28 January 2019 - Value-based contract for Brilinta (ticagrelor) improves member access to the medicine and uniquely includes two-sided financial risk. ...

Read more →

Australian Medical Association warns hospital 'funding crisis' jeopardises patient safety

29 January 2019 - Some $130 billion in Federal Government funding allocated to Australia's public hospitals over four years won't ...

Read more →

Proposal for changes to funded haemophilia treatments

29 January 2019 - PHARMAC is proposing to make changes to the funding of haemophilia treatments from 1 May 2019, ...

Read more →

CVS to cover migraine drugs from Teva, Lilly; excludes Amgen

26 January 2019 - CVS Health has added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly to its list ...

Read more →

Vertex’s CF drug gets label extension as pricing row continues Vertex’s CF drug gets label extension as pricing row continues

23 January 2019 - While UK cystic fibrosis patients continue their long wait for access to Vertex’s Orkambi, the drug ...

Read more →

Access, value and investment: making the right choices for a healthy Australia

22 January 2019 - Medicines Australia has today lodged its submission to the 2019-2020 Federal Budget. ...

Read more →

Gene therapy drug Kymriah should be publicly covered if manufacturer drops price, report recommends

16 January 2019 - A groundbreaking gene therapy for cancer could cost the Canadian health care system more than $400 ...

Read more →